FDA – Comments Submitted to FDA on Rare Pediatric Disease Priority Review Vouchers

Regulatory Comments

Comments Submitted to FDA on Rare Pediatric Disease Priority Review Vouchers. (Docket Number: FDA-2014-D-1461-0001).

Click here to read the comments.

Related

FDA – Comments submitted regarding Public Notification of Emerging Postmarket Medical Device Signals (“Emerging Signals”)

FDA – Comments submitted regarding Clinical Outcome Assessment Compendium

CIOMS – Comments submitted regarding the public consultation on the Revision of CIOMS 2002 International Ethical Guidelines for Biomedical Research Involving Human Subjects